Skip to main content

Cyclooxygenase in the Lamb Ductus Arteriosus: Developmental Changes and Upregulation

  • Chapter
Advances in Prostaglandin and Leukotriene Research

Part of the book series: Medical Science Symposia Series ((MSSS,volume 16))

  • 84 Accesses

Abstract

The ductus arteriosus is kept patent in the fetus by a process involving prostaglandin (PG) E2, both local and blood-borne, as the main effector [1]. The PGE2-based relaxing mechanism develops early in gestation and, in fact, with a premature birth its intramural component may prevail over the oxygen constriction [1]. This knowledge has, on one hand, introduced indomethacin in the management of prematurely born infants with persistent ductus and, on the other hand, has highlighted potential detrimental effects on the unborn child of nonsteroidal anti-inflammatory drugs taken by the mother. The realization now that PGE2 may originate from two cyclooxygenase (COX) isoforms, COX1 and COX2, has added complexity but, at the same time, has broadened the scope of any therapeutic intervention.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Smith GCS. The pharmacology of the ductus arteriosus. Pharmacol Rev 1998; 50: 35–58.

    PubMed  CAS  Google Scholar 

  2. Chang C-C, Boyce S, Brideau C, et al. Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745, 337: a novel anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. J Pharmacol Exp Ther 1995; 274: 1531–37.

    Google Scholar 

  3. Coceani F, Huhtanen D, Hamilton NC, Bishai I, 011ey PM. Involvement of intramural prostaglandin E2 in prenatal patency of the lamb ductus arteriosus. Can J Physiol Pharmacol 1986; 64: 737–44.

    Article  PubMed  CAS  Google Scholar 

  4. Swierkosz TA, Mitchell JA, Warner TD, Botting RM, Vane JR. Co-induction of nitric oxide synthase and cyclooxygenase: interactions between nitric oxide and prostanoids. Br J Pharmacol 1995; 114: 1335–42.

    Article  PubMed  CAS  Google Scholar 

  5. Bishop-Bailey D, Pepper JR, Larkin SW, Mitchell JA. Differential induction of cyclooxygenase-2 in human arterial and venous smooth muscle - Role of endogenous prostanoids. Arterioscler Thromb Vasc Biol 1998; 18: 1655–61.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Coceani, F., Ackerley, C., Seidlitz, E., Kelsey, L. (2001). Cyclooxygenase in the Lamb Ductus Arteriosus: Developmental Changes and Upregulation. In: Samuelsson, B., Paoletti, R., Folco, G.C., Granström, E., Nicosia, S. (eds) Advances in Prostaglandin and Leukotriene Research. Medical Science Symposia Series, vol 16. Springer, Dordrecht. https://doi.org/10.1007/978-94-015-9721-0_26

Download citation

  • DOI: https://doi.org/10.1007/978-94-015-9721-0_26

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-90-481-5881-2

  • Online ISBN: 978-94-015-9721-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics